Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 7, 2014; 20(37): 13273-13283
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13273
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13273
Ever-changing endoscopic treatment for early gastric cancer: Yesterday-today-tomorrow
Mi-Young Kim, Jun-Hyung Cho, Joo Young Cho, Digestive Disease Center, Soonchunhyang University Hospital, Seoul 140-887, South Korea
Author contributions: Kim MY wrote the paper; Cho JH collected the reference and data; Cho JY provided the advice for this work.
Correspondence to: Joo Young Cho, MD, Digestive Disease Center, Soonchunhyang University Hospital, 59 Daesagwan-ro, Yongsan-gu, Seoul 140-887, South Korea. cjy6695@dreamwiz.com
Telephone: +82-2-7099202 Fax: +82-2-7099696
Received: October 28, 2013
Revised: February 10, 2014
Accepted: April 30, 2014
Published online: October 7, 2014
Revised: February 10, 2014
Accepted: April 30, 2014
Published online: October 7, 2014
Core Tip
Core tip: Endoscopic treatment of early gastric cancer (EGC) has been evolved along with the expansion of ESD indication and toward the question of how to achieve accurate risk assessment of lymph node metastasis (LNM). To achieve curative endoscopic treatment, not only accurate endoscopic diagnosis but precise selection of the patient of EGC without LNM should be preceded. Recently, endomicroscopy has been introduced to provide precise microscopic visualization of histology. Moreover, sentinel node navigation surgery combined ESD and hybrid natural orifice transluminal endoscopic surgery have been reported as a new minimally invasive treatment option for the EGC patients with high risk of LNM.